InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Spragens Jeffrey G, Director. Director active across 2 companies, notably Big Cypress Acquisition Corp.. In total, 3 filings have been recorded. Total volume traded: €226k. The latest transaction was disclosed on 20 May 2022 — J. Regulator: SEC (Form 4). All data is free.
Declarations3 total
0299,002 shares0
Common Stock
SEC:0001209191-22-031401:0·
€113,10213,000 shares@ €8.7002100.0% of flow
Common Stock
SEC:0001493152-21-024641·
Ideal exit: 28 Jun 2022 (T+270)
€113,10213,000 shares@ €8.700250.0% of flow
Common Stock
SEC:0001493152-21-024641:0·
Ideal exit: 28 Jun 2022 (T+270)
3 of 3 declarations
About Spragens Jeffrey G
Jeffrey G. Spragens is a Board Member of Big Cypress Acquisition Corp. and SAB Biotherapeutics, Inc. He brings his expertise in corporate governance and strategy, contributing to the direction and oversight of operations for these companies.
